Indication · Neurology & Neurosurgery
Brain tumors
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
106
Cleared or approved since 2000
PMA and De Novo
11
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
80
450 device trials in all
Devices
10 devices via PMA. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Optune
Novocure, GmbH · PMA · Stimulator, Low Electric Field, Tumor Treatment · newest 2024 · 12 decisions
9 more devices with a free account
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- CONVIVO EndomicroscopyRecruiting
Northwell HealthAcademic, hospital or other
NCT06087393 · 30 participants (planned) · Start Jan 8, 2024 · Primary completion Oct 1, 2028
Device: CONVIVO · For: Brain Tumor
Sites: Manhasset, New York
449 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
Research
- Device studies on glioblastoma across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.